RU97112144A - Derivatives of aryl and heteroaryl sulphonamides, their production and use as antagonists of endothelin - Google Patents
Derivatives of aryl and heteroaryl sulphonamides, their production and use as antagonists of endothelinInfo
- Publication number
- RU97112144A RU97112144A RU97112144/04A RU97112144A RU97112144A RU 97112144 A RU97112144 A RU 97112144A RU 97112144/04 A RU97112144/04 A RU 97112144/04A RU 97112144 A RU97112144 A RU 97112144A RU 97112144 A RU97112144 A RU 97112144A
- Authority
- RU
- Russia
- Prior art keywords
- methoxyphenoxy
- hydroxyethoxy
- tert
- phenyl
- pyridin
- Prior art date
Links
- -1 heteroaryl sulphonamides Chemical class 0.000 title claims 196
- 102000002045 Endothelin Human genes 0.000 title claims 3
- 108050009340 Endothelin Proteins 0.000 title claims 3
- ZUBDGKVDJUIMQQ-UBFCDGJISA-N Endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 title claims 3
- 238000004519 manufacturing process Methods 0.000 title claims 2
- 230000003042 antagnostic Effects 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- 125000005418 aryl aryl group Chemical group 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims 43
- 125000000217 alkyl group Chemical group 0.000 claims 19
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 19
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 12
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 11
- 125000000623 heterocyclic group Chemical group 0.000 claims 9
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims 9
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims 6
- 125000004494 ethyl ester group Chemical group 0.000 claims 6
- 229910052739 hydrogen Inorganic materials 0.000 claims 6
- 239000001257 hydrogen Substances 0.000 claims 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 6
- QRKMGCXMJZJTGC-UHFFFAOYSA-N ethyl N-pyridin-2-ylcarbamate Chemical compound CCOC(=O)NC1=CC=CC=N1 QRKMGCXMJZJTGC-UHFFFAOYSA-N 0.000 claims 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 5
- 239000002253 acid Substances 0.000 claims 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-M benzoate Chemical compound [O-]C(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-M 0.000 claims 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 4
- 201000010099 disease Diseases 0.000 claims 4
- OUCYWJAACMAXQD-UHFFFAOYSA-N pyridin-2-ylcarbamic acid Chemical compound OC(=O)NC1=CC=CC=N1 OUCYWJAACMAXQD-UHFFFAOYSA-N 0.000 claims 4
- 239000005711 Benzoic acid Substances 0.000 claims 3
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 3
- 235000010233 benzoic acid Nutrition 0.000 claims 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims 3
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims 3
- 230000003993 interaction Effects 0.000 claims 3
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 239000011780 sodium chloride Substances 0.000 claims 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 2
- 206010002383 Angina pectoris Diseases 0.000 claims 2
- 210000004204 Blood Vessels Anatomy 0.000 claims 2
- 206010020772 Hypertension Diseases 0.000 claims 2
- 206010061255 Ischaemia Diseases 0.000 claims 2
- 241001024304 Mino Species 0.000 claims 2
- 125000004466 alkoxycarbonylamino group Chemical group 0.000 claims 2
- 125000002344 aminooxy group Chemical group [H]N([H])O[*] 0.000 claims 2
- 125000000043 benzamido group Chemical group [H]N([*])C(=O)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims 2
- YIYZHARUXWKUEN-UHFFFAOYSA-N benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1.NS(=O)(=O)C1=CC=CC=C1 YIYZHARUXWKUEN-UHFFFAOYSA-N 0.000 claims 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 2
- RFIOZSIHFNEKFF-UHFFFAOYSA-M piperazine-1-carboxylate Chemical compound [O-]C(=O)N1CCNCC1 RFIOZSIHFNEKFF-UHFFFAOYSA-M 0.000 claims 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 claims 2
- VJIZGIHZSNBTPB-UHFFFAOYSA-N 2-[[3-[(4-tert-butylphenyl)sulfonylamino]-5-(2-hydroxyethoxy)-4-(2-methoxyphenoxy)benzoyl]amino]acetic acid Chemical compound COC1=CC=CC=C1OC(C(=CC(=C1)C(=O)NCC(O)=O)OCCO)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 VJIZGIHZSNBTPB-UHFFFAOYSA-N 0.000 claims 1
- 125000003006 2-dimethylaminoethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 claims 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims 1
- NBFYRGLBBDIWRF-UHFFFAOYSA-N 3-(1,3-benzodioxol-5-ylsulfonylamino)-4-(2-chloro-5-methoxyphenoxy)-5-(2-hydroxyethoxy)-N-phenylbenzamide Chemical compound COC1=CC=C(Cl)C(OC=2C(=CC(=CC=2NS(=O)(=O)C=2C=C3OCOC3=CC=2)C(=O)NC=2C=CC=CC=2)OCCO)=C1 NBFYRGLBBDIWRF-UHFFFAOYSA-N 0.000 claims 1
- NQKUYZBQDYGAPV-UHFFFAOYSA-N 3-(1,3-benzodioxol-5-ylsulfonylamino)-4-(2-chloro-5-methoxyphenoxy)-5-(2-hydroxyethoxy)benzoic acid Chemical compound COC1=CC=C(Cl)C(OC=2C(=CC(=CC=2NS(=O)(=O)C=2C=C3OCOC3=CC=2)C(O)=O)OCCO)=C1 NQKUYZBQDYGAPV-UHFFFAOYSA-N 0.000 claims 1
- QPTHJPKWQPPKSO-UHFFFAOYSA-N 3-(1,3-benzodioxol-5-ylsulfonylamino)-5-(2-hydroxyethoxy)-4-(2-methoxyphenoxy)benzoic acid Chemical compound COC1=CC=CC=C1OC(C(=CC(=C1)C(O)=O)OCCO)=C1NS(=O)(=O)C1=CC=C(OCO2)C2=C1 QPTHJPKWQPPKSO-UHFFFAOYSA-N 0.000 claims 1
- MTAYQGBVKHCWSB-UHFFFAOYSA-N 3-(2,3-dihydroxypropoxy)-4-(3-methoxyphenoxy)-5-[(4-methoxyphenyl)sulfonylamino]-N-phenylbenzamide Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)NC1=CC(C(=O)NC=2C=CC=CC=2)=CC(OCC(O)CO)=C1OC1=CC=CC(OC)=C1 MTAYQGBVKHCWSB-UHFFFAOYSA-N 0.000 claims 1
- BRXIPWHDEHXYJT-UHFFFAOYSA-N 3-(2,3-dihydroxypropoxy)-4-(3-methoxyphenoxy)-5-[(4-methoxyphenyl)sulfonylamino]benzoic acid Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)NC1=CC(C(O)=O)=CC(OCC(O)CO)=C1OC1=CC=CC(OC)=C1 BRXIPWHDEHXYJT-UHFFFAOYSA-N 0.000 claims 1
- QXMOKSIZCFOTGF-UHFFFAOYSA-N 3-(2-hydroxyethoxy)-4-(2-methoxyphenoxy)-5-[(4-methylphenyl)sulfonylamino]benzoic acid Chemical compound COC1=CC=CC=C1OC(C(=CC(=C1)C(O)=O)OCCO)=C1NS(=O)(=O)C1=CC=C(C)C=C1 QXMOKSIZCFOTGF-UHFFFAOYSA-N 0.000 claims 1
- FADFHHPLYGYQIF-UHFFFAOYSA-N 3-(2-hydroxyethoxy)-4-(2-methoxyphenoxy)-5-[(4-methylsulfanylphenyl)sulfonylamino]benzoic acid Chemical compound COC1=CC=CC=C1OC(C(=CC(=C1)C(O)=O)OCCO)=C1NS(=O)(=O)C1=CC=C(SC)C=C1 FADFHHPLYGYQIF-UHFFFAOYSA-N 0.000 claims 1
- KBYSOODDGVQVDI-UHFFFAOYSA-N 3-(2-hydroxyethoxy)-4-(2-methoxyphenoxy)-5-[(5-propan-2-ylpyridin-2-yl)sulfonylamino]benzoic acid Chemical compound COC1=CC=CC=C1OC(C(=CC(=C1)C(O)=O)OCCO)=C1NS(=O)(=O)C1=CC=C(C(C)C)C=N1 KBYSOODDGVQVDI-UHFFFAOYSA-N 0.000 claims 1
- RBQWROHWWPMMKG-UHFFFAOYSA-N 3-[(4-tert-butylphenyl)sulfonylamino]-4-(2-chloro-5-methoxyphenoxy)-5-(2-hydroxyethoxy)benzoic acid Chemical compound COC1=CC=C(Cl)C(OC=2C(=CC(=CC=2NS(=O)(=O)C=2C=CC(=CC=2)C(C)(C)C)C(O)=O)OCCO)=C1 RBQWROHWWPMMKG-UHFFFAOYSA-N 0.000 claims 1
- FZTWIGAELUSLAK-UHFFFAOYSA-N 3-[(4-tert-butylphenyl)sulfonylamino]-5-(2,3-dihydroxypropoxy)-4-(3-methoxyphenoxy)-N-phenylbenzamide Chemical compound COC1=CC=CC(OC=2C(=CC(=CC=2NS(=O)(=O)C=2C=CC(=CC=2)C(C)(C)C)C(=O)NC=2C=CC=CC=2)OCC(O)CO)=C1 FZTWIGAELUSLAK-UHFFFAOYSA-N 0.000 claims 1
- KSYWUMQDPMVPLF-UHFFFAOYSA-N 3-[(4-tert-butylphenyl)sulfonylamino]-5-(2-hydroxyethoxy)-4-(2-methoxyphenoxy)-N-(pyridin-3-ylmethyl)benzamide Chemical compound COC1=CC=CC=C1OC(C(=CC(=C1)C(=O)NCC=2C=NC=CC=2)OCCO)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 KSYWUMQDPMVPLF-UHFFFAOYSA-N 0.000 claims 1
- ZRKZNDTWTWJYCM-UHFFFAOYSA-N 3-[(4-tert-butylphenyl)sulfonylamino]-5-(2-hydroxyethoxy)-4-(2-methoxyphenoxy)-N-phenylbenzamide Chemical compound COC1=CC=CC=C1OC(C(=CC(=C1)C(=O)NC=2C=CC=CC=2)OCCO)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 ZRKZNDTWTWJYCM-UHFFFAOYSA-N 0.000 claims 1
- FIRWUFSOHBIAQG-UHFFFAOYSA-N 3-[(4-tert-butylphenyl)sulfonylamino]-5-(2-hydroxyethoxy)-4-(2-methoxyphenoxy)benzoic acid Chemical compound COC1=CC=CC=C1OC(C(=CC(=C1)C(O)=O)OCCO)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 FIRWUFSOHBIAQG-UHFFFAOYSA-N 0.000 claims 1
- QYUREKUZQDLGQY-UHFFFAOYSA-N 4-(2-chloro-5-methoxyphenoxy)-3-(2-hydroxyethoxy)-5-[(4-methoxyphenyl)sulfonylamino]-N-phenylbenzamide Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)NC1=CC(C(=O)NC=2C=CC=CC=2)=CC(OCCO)=C1OC1=CC(OC)=CC=C1Cl QYUREKUZQDLGQY-UHFFFAOYSA-N 0.000 claims 1
- LMFVYZKWWJTRGH-UHFFFAOYSA-N 4-(2-chloro-5-methoxyphenoxy)-3-(2-hydroxyethoxy)-5-[(4-methoxyphenyl)sulfonylamino]benzoic acid Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)NC1=CC(C(O)=O)=CC(OCCO)=C1OC1=CC(OC)=CC=C1Cl LMFVYZKWWJTRGH-UHFFFAOYSA-N 0.000 claims 1
- RFQSCXXRTALZPI-UHFFFAOYSA-N 4-tert-butyl-N-[2-(2-chloro-5-methoxyphenoxy)-3-(2-hydroxyethoxy)-5-(morpholine-4-carbonyl)phenyl]benzenesulfonamide Chemical compound COC1=CC=C(Cl)C(OC=2C(=CC(=CC=2NS(=O)(=O)C=2C=CC(=CC=2)C(C)(C)C)C(=O)N2CCOCC2)OCCO)=C1 RFQSCXXRTALZPI-UHFFFAOYSA-N 0.000 claims 1
- VUMGTJBGORWCET-UHFFFAOYSA-N 4-tert-butyl-N-[2-(2-chloro-5-methoxyphenoxy)-3-(2-hydroxyethoxy)phenyl]benzenesulfonamide Chemical compound COC1=CC=C(Cl)C(OC=2C(=CC=CC=2NS(=O)(=O)C=2C=CC(=CC=2)C(C)(C)C)OCCO)=C1 VUMGTJBGORWCET-UHFFFAOYSA-N 0.000 claims 1
- HSEJAABARJUYSR-UHFFFAOYSA-N 4-tert-butyl-N-[3-(2-hydroxyethoxy)-2-(2-methoxyphenoxy)-5-(morpholine-4-carbonyl)phenyl]benzenesulfonamide Chemical compound COC1=CC=CC=C1OC(C(=CC(=C1)C(=O)N2CCOCC2)OCCO)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 HSEJAABARJUYSR-UHFFFAOYSA-N 0.000 claims 1
- LJXSLZNIAPALGQ-UHFFFAOYSA-N 4-tert-butyl-N-[3-(2-hydroxyethoxy)-2-(2-methoxyphenoxy)-5-(piperidine-1-carbonyl)phenyl]benzenesulfonamide Chemical compound COC1=CC=CC=C1OC(C(=CC(=C1)C(=O)N2CCCCC2)OCCO)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 LJXSLZNIAPALGQ-UHFFFAOYSA-N 0.000 claims 1
- QYXANYSYEWCYLT-UHFFFAOYSA-N 4-tert-butyl-N-[3-(2-hydroxyethoxy)-2-(3-methoxyphenoxy)-5-(morpholine-4-carbonyl)phenyl]benzenesulfonamide Chemical compound COC1=CC=CC(OC=2C(=CC(=CC=2NS(=O)(=O)C=2C=CC(=CC=2)C(C)(C)C)C(=O)N2CCOCC2)OCCO)=C1 QYXANYSYEWCYLT-UHFFFAOYSA-N 0.000 claims 1
- OZJIQSPQLVEIIA-UHFFFAOYSA-N 4-tert-butyl-N-[5-cyano-3-(2,3-dihydroxypropoxy)-2-(2-methoxyphenoxy)phenyl]benzenesulfonamide Chemical compound COC1=CC=CC=C1OC(C(=CC(=C1)C#N)OCC(O)CO)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 OZJIQSPQLVEIIA-UHFFFAOYSA-N 0.000 claims 1
- MGJDERTYCSYSJV-UHFFFAOYSA-N 4-tert-butyl-N-[5-cyano-3-(2-hydroxyethoxy)-2-(3-methoxyphenoxy)phenyl]benzenesulfonamide Chemical compound COC1=CC=CC(OC=2C(=CC(=CC=2NS(=O)(=O)C=2C=CC(=CC=2)C(C)(C)C)C#N)OCCO)=C1 MGJDERTYCSYSJV-UHFFFAOYSA-N 0.000 claims 1
- USENFRBCKALVCW-UHFFFAOYSA-N C(C)(=O)ON(C(C1=CC(=C(C(=C1)OCCOC(NC1=NC=CC=C1)=O)OC1=C(C=CC=C1)OC)NS(=O)(=O)C1=CC=C(C=C1)C(C)(C)C)=O)CC1=CC=CC=C1 Chemical compound C(C)(=O)ON(C(C1=CC(=C(C(=C1)OCCOC(NC1=NC=CC=C1)=O)OC1=C(C=CC=C1)OC)NS(=O)(=O)C1=CC=C(C=C1)C(C)(C)C)=O)CC1=CC=CC=C1 USENFRBCKALVCW-UHFFFAOYSA-N 0.000 claims 1
- MKDSTFWOAGEKBU-UHFFFAOYSA-N C(N)(OCC(NC(C1=CC(=C(C(=C1)OCCO)OC1=C(C=CC=C1)OC)NS(=O)(=O)C1=CC=C(C=C1)C(C)(C)C)=O)C(C)(C)C)=O Chemical compound C(N)(OCC(NC(C1=CC(=C(C(=C1)OCCO)OC1=C(C=CC=C1)OC)NS(=O)(=O)C1=CC=C(C=C1)C(C)(C)C)=O)C(C)(C)C)=O MKDSTFWOAGEKBU-UHFFFAOYSA-N 0.000 claims 1
- NZUGQVZITSSLIZ-UHFFFAOYSA-N N-[2-(2-hydroxyethoxy)-3-(2-methoxyphenoxy)-6-methylpyridin-4-yl]-5-propan-2-ylpyridine-2-sulfonamide Chemical compound COC1=CC=CC=C1OC(C(=NC(C)=C1)OCCO)=C1NS(=O)(=O)C1=CC=C(C(C)C)C=N1 NZUGQVZITSSLIZ-UHFFFAOYSA-N 0.000 claims 1
- VJENEVUMPDYUDM-UHFFFAOYSA-N N-[2-(3-methoxyphenoxy)-5-(morpholine-4-carbonyl)-3-(2-pyridin-2-yloxyethoxy)phenyl]-4-methylsulfanylbenzenesulfonamide Chemical compound COC1=CC=CC(OC=2C(=CC(=CC=2NS(=O)(=O)C=2C=CC(SC)=CC=2)C(=O)N2CCOCC2)OCCOC=2N=CC=CC=2)=C1 VJENEVUMPDYUDM-UHFFFAOYSA-N 0.000 claims 1
- DONWNAHQRMZNSM-UHFFFAOYSA-N N-[2-(3-methoxyphenoxy)-5-(morpholine-4-carbonyl)-3-(2-pyrimidin-2-yloxyethoxy)phenyl]-4-methylsulfanylbenzenesulfonamide Chemical compound COC1=CC=CC(OC=2C(=CC(=CC=2NS(=O)(=O)C=2C=CC(SC)=CC=2)C(=O)N2CCOCC2)OCCOC=2N=CC=CN=2)=C1 DONWNAHQRMZNSM-UHFFFAOYSA-N 0.000 claims 1
- CTFCLBNDGCLYJC-UHFFFAOYSA-N N-[3-(2,3-dihydroxypropoxy)-2-(3-methoxyphenoxy)-5-(morpholine-4-carbonyl)phenyl]-4-methylsulfanylbenzenesulfonamide Chemical compound COC1=CC=CC(OC=2C(=CC(=CC=2NS(=O)(=O)C=2C=CC(SC)=CC=2)C(=O)N2CCOCC2)OCC(O)CO)=C1 CTFCLBNDGCLYJC-UHFFFAOYSA-N 0.000 claims 1
- VUNUPPSQZRHABE-UHFFFAOYSA-N N-[3-(2-hydroxyethoxy)-2-(2-methoxyphenoxy)-5-(morpholine-4-carbonyl)phenyl]-4-methoxybenzenesulfonamide Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)NC1=CC(C(=O)N2CCOCC2)=CC(OCCO)=C1OC1=CC=CC=C1OC VUNUPPSQZRHABE-UHFFFAOYSA-N 0.000 claims 1
- YSUDMCJJYLBLED-UHFFFAOYSA-N N-[3-(2-hydroxyethoxy)-2-(2-methoxyphenoxy)-5-(morpholine-4-carbonyl)phenyl]-4-methylbenzenesulfonamide Chemical compound COC1=CC=CC=C1OC(C(=CC(=C1)C(=O)N2CCOCC2)OCCO)=C1NS(=O)(=O)C1=CC=C(C)C=C1 YSUDMCJJYLBLED-UHFFFAOYSA-N 0.000 claims 1
- CWBCLHMXQQOGSR-UHFFFAOYSA-N N-[3-(2-hydroxyethoxy)-2-(3-methoxyphenoxy)-5-(morpholine-4-carbonyl)phenyl]-4-methylsulfanylbenzenesulfonamide Chemical compound COC1=CC=CC(OC=2C(=CC(=CC=2NS(=O)(=O)C=2C=CC(SC)=CC=2)C(=O)N2CCOCC2)OCCO)=C1 CWBCLHMXQQOGSR-UHFFFAOYSA-N 0.000 claims 1
- SPKDKEYOMHVGPB-UHFFFAOYSA-N N-phenylpyridine-2-sulfonamide Chemical compound C=1C=CC=NC=1S(=O)(=O)NC1=CC=CC=C1 SPKDKEYOMHVGPB-UHFFFAOYSA-N 0.000 claims 1
- FEZCPTBMUFWLLX-UHFFFAOYSA-N OCCOC=1C(=C(C=C(C=1)C(=O)N1CCN(CC1)C)[NH-])OC1=C(C=CC=C1)OC Chemical compound OCCOC=1C(=C(C=C(C=1)C(=O)N1CCN(CC1)C)[NH-])OC1=C(C=CC=C1)OC FEZCPTBMUFWLLX-UHFFFAOYSA-N 0.000 claims 1
- IQPQWNKOIGAROB-UHFFFAOYSA-N [N-]=C=O Chemical compound [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 230000000240 adjuvant Effects 0.000 claims 1
- 125000003282 alkyl amino group Chemical group 0.000 claims 1
- 125000005466 alkylenyl group Chemical group 0.000 claims 1
- KXDAEFPNCMNJSK-UHFFFAOYSA-N benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 claims 1
- CKDWPUIZGOQOOM-UHFFFAOYSA-N carbamoyl chloride Chemical compound NC(Cl)=O CKDWPUIZGOQOOM-UHFFFAOYSA-N 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 239000007795 chemical reaction product Substances 0.000 claims 1
- 230000005494 condensation Effects 0.000 claims 1
- 238000009833 condensation Methods 0.000 claims 1
- 239000012050 conventional carrier Substances 0.000 claims 1
- 229940079593 drugs Drugs 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- RXRJKRQFRYXGMV-UHFFFAOYSA-N methyl 3-[(4-tert-butylphenyl)sulfonylamino]-5-(2-hydroxyethoxy)-4-(3-methoxyphenoxy)benzoate Chemical compound C=1C=CC(OC)=CC=1OC=1C(OCCO)=CC(C(=O)OC)=CC=1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 RXRJKRQFRYXGMV-UHFFFAOYSA-N 0.000 claims 1
- 150000002829 nitrogen Chemical group 0.000 claims 1
- 239000007800 oxidant agent Substances 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 claims 1
- 125000006239 protecting group Chemical group 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 150000003458 sulfonic acid derivatives Chemical class 0.000 claims 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 239000011593 sulfur Substances 0.000 claims 1
- 230000001131 transforming Effects 0.000 claims 1
Claims (1)
где
R1 обозначает фенил, замещенный фенил или гетероциклил;
R2 обозначает фенил или замещенный фенил;
R3 обозначает водород, (низший) алкил, циано, карбокси, этерифицированную карбоксигруппу, фенил, замещенный фенил, гетероциклил или группу -CONR5R6 или -NR5COR7;
R4 обозначает водород или (низший) алкил;
R5 обозначает водород или радикал R7; и
R6 обозначает -(CH2)mR7; или
R5 и R6 вместе с атомом азота, к которому они присоединены, обозначают гетероциклильный остаток;
R7 обозначает фенил, замещенный фенил, циклоалкил, гетероциклил, (низший)алкил, циано(низший)алкил, гидрокси(низший)алкил, ди(низший)алкиламино(низший)алкил, карбокси(низший)алкил, (низший)алкоксикарбонил(низший)алкил, (низший)алкоксикарбониламино(низший)алкил или фенил(низший)алкоксикарбонил;
Ra обозначает водород, (низший)алкил или гидрокси;
Rb обозначает водород или (низший)алкил;
Z обозначает гидрокси, амино или группу -OR8, -OC(O)NHR8, -OC(O)OR8, -NHC(O)NHR8 или -NHC(O)OR8
R8 обозначает гетероциклил, фенил, замещенный фенил или (низший)алкил;
А и Y каждый независимо друг от друга обозначает кислород или серу;
X обозначает азот или СН;
m равно 0, 1 или 2; и
n равно 0, 1 или 2;
и их фармацевтически приемлемые соли.1. The compounds of formula I
Where
R 1 denotes phenyl, substituted phenyl or heterocyclyl;
R 2 is phenyl or substituted phenyl;
R 3 is hydrogen, (lower) alkyl, cyano, carboxy, esterified carboxy, phenyl, substituted phenyl, heterocyclyl, or —CONR 5 R 6 or —NR 5 COR 7 ;
R 4 denotes hydrogen or (lower) alkyl;
R 5 denotes hydrogen or the radical R 7 ; and
R 6 means - (CH 2 ) m R 7 ; or
R 5 and R 6 together with the nitrogen atom to which they are attached, denote a heterocyclyl residue;
R 7 denotes phenyl, substituted phenyl, cycloalkyl, heterocyclyl, (lower) alkyl, cyano (lower) alkyl, hydroxy (lower) alkyl, di (lower) alkylamino (lower) alkyl, carboxy (lower) alkyl, (lower) alkoxycarbonyl ( lower) alkyl, (lower) alkoxycarbonylamino (lower) alkyl or phenyl (lower) alkoxycarbonyl;
R a is hydrogen, (lower) alkyl or hydroxy;
R b denotes hydrogen or (lower) alkyl;
Z is hydroxy, amino or the group —OR 8 , —OC (O) NHR 8 , —OC (O) OR 8 , —NHC (O) NHR 8 or —NHC (O) OR 8
R 8 is heterocyclyl, phenyl, substituted phenyl or (lower) alkyl;
A and Y are each independently oxygen or sulfur;
X is nitrogen or CH;
m is 0, 1 or 2; and
n is 0, 1 or 2;
and their pharmaceutically acceptable salts.
20. Соединения по. 14, в которых R1 обозначает гетероциклил.19. Compounds according to claim 17: para-tert-butyl-N- [2- (2-hydroxyethoxy) -3- (ortho-methoxyphenoxy) -6-methyl-4-pyridyl] benzenesulfonamide, para-tert-butyl-N - [2- (2-hydroxyethoxy) -3- (3-methoxyphenoxy) -6-methyl-4-pyridyl] benzenesulfonamide, 4-tert-butyl-N- [2- (2-hydroxyethoxy) -3- (2- methoxyphenoxy) -6-phenylpyrid-4-yl] benzenesulfonamide,
20. Compounds by. 14, in which R 1 denotes heterocyclyl.
где R2, R3, R4, Ra, Rb, A, X, Y, Z и n имеют указанные выше значения, а амино- или гидроксигруппы, которые необязательно содержатся в R3 и Z, находятся в защищенной форме, с реакционноспособным производным сульфоновой кислоты формулы R1SO2OH; или
взаимодействие соединения формулы III
где R1-R4, А и X имеют указанные выше значения, в присутствии основания с соединением формулы HalCH2(CRaRb)nCH2OH, где Hal обозначает галоген, а гидроксигруппа(ы), присутствующая(ие) в последнем соединении, могут находиться в защищенной форме; или взаимодействие соединения формулы I, где Z обозначает гидрокси или амино, а другие амино- или гидроксигруппы, которые могут присутствовать в молекуле, находятся в защищенной форме, c изоцианатом формулы R8NCO или карбамоилхлоридом формулы R8NCOCl, где R8 имеет указанные выше значения, или с фосгеном и затем со спиртом формулы R8OH; или с эфиром хлормуравьиной кислоты формулы R8OC(O)Сl; или конденсацию соединения формулы I, где R3 обозначает карбокси, с соединением формулы NHR5R6, где R5 и R6 имеют указанные выше значения; или взаимодействие соединения формулы I, где R3 обозначает циано, а остальные символы имеют указанные выше значения, с NH4Cl и азидом натрия; или обработку соединения формулы IV
где R1-R4, Rb, A, X и Y имеют указанные выше значения, окислителем, при необходимости удаление амино- или гидроксизащитных групп, содержащихся в продукте реакции, и при необходимости трансформирование заместителей, содержащихся в полученном соединении формулы I, и/или превращение полученного соединения формулы I в соль.28. The method of obtaining compounds for PP. 1-26, including the interaction of the compounds of formula II
where R 2 , R 3 , R 4 , R a , R b , A, X, Y, Z and n are as defined above, and the amino or hydroxy groups, which are optionally contained in R 3 and Z, are in protected form, with a reactive sulfonic acid derivative of the formula R 1 SO 2 OH; or
the interaction of the compounds of formula III
where R 1 -R 4 , A and X have the above values, in the presence of a base with a compound of the formula HalCH 2 (CR a R b ) n CH 2 OH, where Hal means halogen, and the hydroxy group (s) present (s) in the last compound may be in protected form; or reacting a compound of formula I, wherein Z is hydroxy or amino, and other amino or hydroxy groups that may be present in the molecule are in protected form, with an isocyanate of formula R 8 NCO or carbamoyl chloride of formula R 8 NCOCl, where R 8 is as defined above values, or with phosgene and then with an alcohol of the formula R 8 OH; or with chloroformate ester of the formula R 8 OC (O) Cl; or condensation of a compound of formula I, where R 3 is carboxy, with a compound of the formula NHR 5 R 6 , where R 5 and R 6 are as defined above; or the interaction of the compounds of formula I, where R 3 denotes cyano, and the remaining symbols have the above values, with NH 4 Cl and sodium azide; or treatment of compounds of formula IV
where R 1 -R 4 , R b , A, X and Y have the above values, an oxidizing agent, if necessary, removing the amino or hydroxy protecting groups contained in the reaction product, and if necessary, transforming the substituents contained in the resulting compound of formula I, and / or the conversion of the obtained compounds of formula I to salt.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH383894 | 1994-12-20 | ||
CH3079/95 | 1995-10-31 | ||
CH307995 | 1995-10-31 | ||
CH3838/94-8 | 1995-10-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU97112144A true RU97112144A (en) | 1999-07-20 |
RU2163598C2 RU2163598C2 (en) | 2001-02-27 |
Family
ID=31189207
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU97112144/04A RU2163598C2 (en) | 1994-12-20 | 1995-12-04 | Derivatives of aryl- and heteroarylsulfoneamides and pharmaceutical composition based on thereof |
Country Status (25)
Country | Link |
---|---|
US (2) | US5962682A (en) |
EP (1) | EP0799206B1 (en) |
JP (1) | JP2930731B2 (en) |
KR (1) | KR100432843B1 (en) |
CN (1) | CN1136192C (en) |
AT (1) | ATE223899T1 (en) |
AU (1) | AU695255B2 (en) |
BR (1) | BR9510533A (en) |
CA (1) | CA2208011A1 (en) |
CZ (1) | CZ289090B6 (en) |
DE (1) | DE69528198T2 (en) |
DK (1) | DK0799206T3 (en) |
ES (1) | ES2180664T3 (en) |
FI (1) | FI116622B (en) |
HU (1) | HUT77307A (en) |
IL (1) | IL116410A (en) |
MA (1) | MA23745A1 (en) |
MX (1) | MX9704588A (en) |
MY (1) | MY113214A (en) |
NO (1) | NO308297B1 (en) |
NZ (1) | NZ297774A (en) |
PT (1) | PT799206E (en) |
RU (1) | RU2163598C2 (en) |
TW (1) | TW474920B (en) |
WO (1) | WO1996019455A1 (en) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5962490A (en) | 1987-09-25 | 1999-10-05 | Texas Biotechnology Corporation | Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
US6613804B2 (en) | 1993-05-20 | 2003-09-02 | Encysive Pharmaceuticals, Inc. | Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
US6376523B1 (en) | 1994-05-20 | 2002-04-23 | Texas Biotechnology Corporation | Benzenesulfonamides and the use thereof to modulate the activity of endothelin |
US6342610B2 (en) | 1993-05-20 | 2002-01-29 | Texas Biotechnology Corp. | N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
US6541498B2 (en) | 1993-05-20 | 2003-04-01 | Texas Biotechnology | Benzenesulfonamides and the use thereof to modulate the activity of endothelin |
BR9510533A (en) * | 1994-12-20 | 1998-07-14 | Hoffmann La Roche | Derivatives of aryl-e hetarylsulfonamide its preparation and its use as endothelin antagonists |
US5977117A (en) | 1996-01-05 | 1999-11-02 | Texas Biotechnology Corporation | Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin |
US5804585A (en) | 1996-04-15 | 1998-09-08 | Texas Biotechnology Corporation | Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin |
US6653331B2 (en) * | 1996-07-03 | 2003-11-25 | Pharmacia & Upjohn Company | Targeted drug delivery using sulfonamide derivatives |
NZ336898A (en) | 1997-04-28 | 2001-10-26 | Texas Biotechnology Corp | Sulfonamides for treatment of endothelin-mediated disorders |
US5783705A (en) | 1997-04-28 | 1998-07-21 | Texas Biotechnology Corporation | Process of preparing alkali metal salys of hydrophobic sulfonamides |
US6191170B1 (en) * | 1998-01-13 | 2001-02-20 | Tularik Inc. | Benzenesulfonamides and benzamides as therapeutic agents |
CA2315614C (en) | 1999-07-29 | 2004-11-02 | Pfizer Inc. | Pyrazoles |
IL149529A0 (en) * | 1999-12-22 | 2002-11-10 | Actelion Pharmaceuticals Ltd | Butyne diol derivatives |
ATE286051T1 (en) | 1999-12-31 | 2005-01-15 | Encysive Pharmaceuticals Inc | SULFONAMIDES AND THEIR DERIVATIVES THAT MODULATE THE ACTIVITY OF ENDOTHELIN |
US6387915B2 (en) | 2000-05-31 | 2002-05-14 | Pfizer Inc. | Isoxazole-sulfonamide endothelin antagonists |
US6670362B2 (en) | 2000-09-20 | 2003-12-30 | Pfizer Inc. | Pyridazine endothelin antagonists |
SE0102764D0 (en) | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
AU2003297398B2 (en) | 2002-12-20 | 2009-09-24 | Amgen Inc. | Asthma and allergic inflammation modulators |
WO2004073619A2 (en) * | 2003-02-14 | 2004-09-02 | Smithkline Beecham Corporation | Ccr8 antagonists |
WO2004074438A2 (en) * | 2003-02-14 | 2004-09-02 | Smithkline Beecham Corporation | Ccr8 antagonists |
CN101903338A (en) * | 2007-12-19 | 2010-12-01 | 安姆根有限公司 | Phenyl acetic acid derivatives as inflammation modulators |
WO2010015623A1 (en) * | 2008-08-05 | 2010-02-11 | Farmaprojects, S. A. | Process for the preparation of endothelin receptor antagonists |
AR076221A1 (en) | 2009-04-09 | 2011-05-26 | Astrazeneca Ab | DERIVED FROM PIRAZOL [4,5-E] PYRIMIDINE AND ITS USE TO TREAT DIABETES AND OBESITY |
CN110092743B (en) * | 2018-01-30 | 2022-03-15 | 中国医学科学院药物研究所 | Benzamide compound, preparation method, application and pharmaceutical composition thereof |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1521932A (en) * | 1976-03-08 | 1978-08-16 | Labaz | Sulphonamide derivatives and process for preparing the same |
GB8708233D0 (en) * | 1987-04-07 | 1987-05-13 | Smith Kline French Lab | Pharmaceutically active compounds |
DE69129611T2 (en) * | 1990-08-20 | 1998-12-17 | Eisai Co Ltd | Sulfonamide derivatives |
TW270116B (en) * | 1991-04-25 | 1996-02-11 | Hoffmann La Roche | |
RU2086544C1 (en) * | 1991-06-13 | 1997-08-10 | Хоффманн-Ля Рош АГ | Benzenesulfonamide derivatives of pyrimidine or their salts, pharmaceutical composition for treatment of diseases associated with endothelin activity |
NZ247440A (en) * | 1992-05-06 | 1995-04-27 | Squibb & Sons Inc | Phenyl sulphonamide derivatives, preparation and pharmaceutical compositions thereof |
TW287160B (en) * | 1992-12-10 | 1996-10-01 | Hoffmann La Roche | |
IL111959A (en) * | 1993-12-17 | 2000-07-16 | Tanabe Seiyaku Co | N-(polysubstituted pyrimidin-4-yl) benzenesulfonamide derivatives their preparation and pharmaceutical compositions containing them |
GB9504854D0 (en) * | 1994-03-31 | 1995-04-26 | Zeneca Ltd | Nitrogen derivatives |
BR9510533A (en) * | 1994-12-20 | 1998-07-14 | Hoffmann La Roche | Derivatives of aryl-e hetarylsulfonamide its preparation and its use as endothelin antagonists |
-
1995
- 1995-12-04 BR BR9510533A patent/BR9510533A/en not_active IP Right Cessation
- 1995-12-04 JP JP8519459A patent/JP2930731B2/en not_active Expired - Fee Related
- 1995-12-04 CN CNB951969595A patent/CN1136192C/en not_active Expired - Fee Related
- 1995-12-04 AT AT95941660T patent/ATE223899T1/en not_active IP Right Cessation
- 1995-12-04 DK DK95941660T patent/DK0799206T3/en active
- 1995-12-04 NZ NZ297774A patent/NZ297774A/en unknown
- 1995-12-04 US US08/860,985 patent/US5962682A/en not_active Expired - Fee Related
- 1995-12-04 CZ CZ19971873A patent/CZ289090B6/en not_active IP Right Cessation
- 1995-12-04 CA CA002208011A patent/CA2208011A1/en not_active Abandoned
- 1995-12-04 ES ES95941660T patent/ES2180664T3/en not_active Expired - Lifetime
- 1995-12-04 EP EP95941660A patent/EP0799206B1/en not_active Expired - Lifetime
- 1995-12-04 HU HU9701811A patent/HUT77307A/en unknown
- 1995-12-04 PT PT95941660T patent/PT799206E/en unknown
- 1995-12-04 DE DE69528198T patent/DE69528198T2/en not_active Expired - Fee Related
- 1995-12-04 AU AU43016/96A patent/AU695255B2/en not_active Ceased
- 1995-12-04 WO PCT/EP1995/004762 patent/WO1996019455A1/en active IP Right Grant
- 1995-12-04 KR KR1019970704136A patent/KR100432843B1/en not_active IP Right Cessation
- 1995-12-04 RU RU97112144/04A patent/RU2163598C2/en active
- 1995-12-06 TW TW084113009A patent/TW474920B/en active
- 1995-12-15 MA MA24096A patent/MA23745A1/en unknown
- 1995-12-15 IL IL11641095A patent/IL116410A/en not_active IP Right Cessation
- 1995-12-18 MY MYPI95003929A patent/MY113214A/en unknown
-
1997
- 1997-06-18 FI FI972629A patent/FI116622B/en not_active IP Right Cessation
- 1997-06-19 MX MX9704588A patent/MX9704588A/en not_active IP Right Cessation
- 1997-06-19 NO NO972841A patent/NO308297B1/en not_active IP Right Cessation
-
1999
- 1999-03-05 US US09/263,034 patent/US6133442A/en not_active Expired - Fee Related
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU97112144A (en) | Derivatives of aryl and heteroaryl sulphonamides, their production and use as antagonists of endothelin | |
US6593327B2 (en) | Compounds and compositions as protease inhibitors | |
AP1236A (en) | Non-pepdyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases. | |
EP2650287B9 (en) | Thiazole Derivative and use thereof as VAP-1 Inhibitor | |
SK56798A3 (en) | Protease inhibitors, pharmaceutical composition containing them and their use | |
HU229479B1 (en) | Pyrimidine-4-one derivatives | |
IL137385A (en) | Inhibitors of ??4 mediated cell adhesion | |
CA2618511A1 (en) | Novel benzothiazolone derivatives | |
EA008865B1 (en) | 2-imino-4-oxothiazoline derivatives | |
RU2007121222A (en) | GIDANTOIN DERIVATIVES USEFUL AS METALLOPROTEINASE INHIBITORS | |
CZ304035B6 (en) | N-phenylarylsulfonylamide compound, pharmaceutical composition in which the compound is comprised as an active component, synthetic intermediate for this compound and process of its preparation | |
KR19990066925A (en) | Thiazole derivative | |
US4315940A (en) | Antidiabetic 1-piperidine-sulfonylureas | |
RU2004129285A (en) | THIAZOLE DERIVATIVES AS NPY RECEPTOR ANTAGONISTS | |
US7951806B2 (en) | Plasminogen activator inhibitor-1 inhibitor | |
JP2011522854A (en) | Imidazolidine derivatives | |
JP2000509039A (en) | Thiadiazolyl (thio) ureas useful as matrix metalloproteinase inhibitors | |
US7605159B2 (en) | Cathepsin cysteine protease inhibitors and their use | |
JP2010077116A5 (en) | ||
US20060264424A1 (en) | Arylsulfonamidobenzylic compounds | |
CZ20021161A3 (en) | Beta-disubstituted metalloproteinase inhibitors | |
EP0944597A1 (en) | Metalloproteinase inhibitors | |
JP2002528442A (en) | Thiazole derivatives | |
JPH10195037A (en) | Phenol derivative | |
WO1998023588A9 (en) | Metalloproteinase inhibitors |